104 related articles for article (PubMed ID: 4571183)
1. Double blind controlled trial of indoramin in the treatment of essential hypertension.
Dollery DT; George DG; Lewis PJ
Br J Pharmacol; 1972 Nov; 46(3):542P-543P. PubMed ID: 4571183
[No Abstract] [Full Text] [Related]
2. [Effectiveness of a compound preparation (DCR 515) in the treatment of arterl hypertension (double blind test)].
Maximilian V; Gavrilă F; Zeană C; Bărbulescu I; Dimitriu CG
Med Interna (Bucur); 1970 Mar; 22(3):297-305. PubMed ID: 5444367
[No Abstract] [Full Text] [Related]
3. Proceedings: Initial clinical experience with indoramin, a new antihypertensive agent.
Royds RB
Br J Pharmacol; 1972 Feb; 44(2):379P-380P. PubMed ID: 4668635
[No Abstract] [Full Text] [Related]
4. A double blind comparison of indoramin with clonidine in the treatment of moderate to severe essential hypertension.
Yajnik BH; Shah JS
J Assoc Physicians India; 1985 May; 33(5):339-43. PubMed ID: 3900029
[No Abstract] [Full Text] [Related]
5. [Contribution to the clinical trial of a new antihypertensive agent].
Capuano G; Santoro C
Rass Int Clin Ter; 1969 May; 49(10):615-20. PubMed ID: 5784808
[No Abstract] [Full Text] [Related]
6. Clinical evaluation of indoramin as the sole agent for the treatment of hypertension.
Kramer R; Rosendorff C; Bloom D
S Afr Med J; 1974 Aug; 48(37):1569-72. PubMed ID: 4851044
[No Abstract] [Full Text] [Related]
7. Clinical evaluation of indoramin, a new antihypertensive agent.
Lewis PJ; George CF; Dollery CT
Eur J Clin Pharmacol; 1973 Dec; 6(4):211-6. PubMed ID: 4359995
[No Abstract] [Full Text] [Related]
8. Indoramin in the treatment of hypertension.
Stannard M; Cohen M
Practitioner; 1983 Oct; 227(1384):1601-5. PubMed ID: 6634630
[No Abstract] [Full Text] [Related]
9. Aliskiren/hydrochlorothiazide (Tekturna HCT) for hypertension.
Med Lett Drugs Ther; 2008 Aug; 50(1293):65-6. PubMed ID: 18719523
[No Abstract] [Full Text] [Related]
10. [Ambulatory therapy of hypertension with briserin].
Jüptner H
Z Allgemeinmed; 1969 Oct; 45(29):1392-4. PubMed ID: 5386127
[No Abstract] [Full Text] [Related]
11. [Suppression of angiotensin-converting enzyme and myocardial ischemia].
Eliseev OM
Ter Arkh; 1999; 71(3):73-6. PubMed ID: 10234773
[No Abstract] [Full Text] [Related]
12. Antihypertensive action and serotonin-induced platelet aggregation during long-term ketanserin treatment in hypertensive patients.
Amery A; Fagard R; Fiocchi R; Lijnen P; Staessen J; Vermylen J
J Cardiovasc Pharmacol; 1984; 6(1):182-5. PubMed ID: 6199602
[TBL] [Abstract][Full Text] [Related]
13. [Longterm treatment with a new antihypertensive agent].
Wolkerstorfer H
Wien Med Wochenschr; 1969 Jun; 119(25):502-4. PubMed ID: 5802413
[No Abstract] [Full Text] [Related]
14. Adrenergic blockade in hypertension.
Lewis PJ; George CF; Dollery CT
Lancet; 1972 Jun; 1(7762):12232-3. PubMed ID: 4113201
[No Abstract] [Full Text] [Related]
15. [Further clinico-therapeutic aspects of therapy of arterial hypertension].
Anselmo B; Basso L
Clin Ter; 1971 Jan; 56(1):55-70. PubMed ID: 5002870
[No Abstract] [Full Text] [Related]
16. [Clinical trials of a new antihypertensive agent].
Signer M; Meyer CH
Praxis; 1968 Oct; 57(43):1499-503. PubMed ID: 4889812
[No Abstract] [Full Text] [Related]
17. Trandolapril: an ACE inhibitor for treatment of hypertension.
Med Lett Drugs Ther; 1996 Nov; 38(988):104-5. PubMed ID: 8941256
[No Abstract] [Full Text] [Related]
18. Aliskiren: new drug. Arterial hypertension: no evidence of clinical efficacy.
Prescrire Int; 2008 Apr; 17(94):47-50. PubMed ID: 18516803
[TBL] [Abstract][Full Text] [Related]
19. Aliskiren (Tekturna) for hypertension.
Med Lett Drugs Ther; 2007 Apr; 49(1258):29-31. PubMed ID: 17415282
[No Abstract] [Full Text] [Related]
20. Managing hypertension in European patients with coronary artery disease: design, results, and clinical implications of INVEST.
Pepine CJ; Conti CR
Ital Heart J; 2004 Jun; 5(6):411-6. PubMed ID: 15320564
[No Abstract] [Full Text] [Related]
[Next] [New Search]
